| Purity | > 99% |
| Form | Lyophilized Powder |
| Milligram | 30mg |
| Purity | > 99% |
| Form | Lyophilized Powder |
| Milligram | 30mg |
❌ For Research Use Only
For laboratory research only. Not for human consumption.
Retatrutide is a triple receptor agonist (GLP-1 / GIP / glucagon) supplied as a lyophilized powder in a sealed pharmaceutical-grade glass vial. Intended for in-vitro and laboratory research applications only.
Mechanism of Action
Retatrutide simultaneously activates glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This makes it a subject of interest in metabolic and energy-homeostasis research.
Specifications
• Sequence: Validated by mass spectrometry (MS/MS)
• Purity: ≥ 98% by HPLC
• Form: Lyophilized powder
• Molecular Weight: 4,859.5 Da
• Storage: 2 – 8 °C, keep dry and away from light
• Shelf Life: 24 months from manufacture date (sealed)
Reconstitution (Research Use)
Reconstitute with bacteriostatic water or sterile saline. Gently swirl — do not shake.
Refrigerate after reconstitution and use within 28 days.
Discard if the solution appears cloudy or contains particulates.
Quality & Testing
Every batch is independently tested by a certified third-party laboratory. A Certificate of Analysis (CoA) confirming purity and identity is available for each lot.
Retatrutide Pen 30mg
€329.90